v3.26.1
Financial Instruments (Tables)
12 Months Ended
Apr. 30, 2026
Disclosure of detailed information about financial instruments [abstract]  
Schedule of Details of Amounts Receivable and Allowances for Credit Losses Details of amounts receivable and allowance for credit losses as of April 30, 2026, 2025 and 2024 are as follows:

 

(in thousands)

 

2026
$

 

 

2025
$

 

 

2024
$

 

Amounts receivable

 

 

2,647

 

 

 

4,165

 

 

 

3,819

 

Allowance for credit losses

 

 

(118

)

 

 

(50

)

 

 

(29

)

Amounts receivable, net

 

 

2,529

 

 

 

4,115

 

 

 

3,790

 

Summary of Classification and Measurement of Financial Assets and Liabilities

At April 30, 2026, the Company is exposed to currency risk through the following assets and liabilities denominated in US dollars and Euros:

 

 

 

Euros

 

 

US Dollars

 

(in thousands)

 

(€)

 

 

(U.S.$)

 

Cash

 

 

551

 

 

 

6,382

 

Amounts receivable

 

 

103

 

 

 

 

 

 

 

654

 

 

 

6,382

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

 

(510

)

 

 

(1,473

)

Leases

 

 

(100

)

 

 

 

 

 

(610

)

 

 

(1,473

)

 

 

 

 

 

 

 

Net

 

 

44

 

 

 

4,909

 

Schedule of Contractual Cash Flow Requirements

Contractual cash flow requirements as of April 30, 2026 were as follows:

 

 

 

< 1
year

 

 

1 - 2
years

 

 

2 - 5
years

 

 

>5
years

 

 

Total

 

(in thousands)

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Accounts payable and accrued liabilities

 

 

4,178

 

 

 

 

 

 

 

 

 

 

 

 

4,178

 

Leases

 

 

670

 

 

 

670

 

 

 

1,749

 

 

 

1,295

 

 

 

4,384

 

Total

 

 

4,848

 

 

 

670

 

 

 

1,749

 

 

 

1,295

 

 

 

8,562